Insights on the Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Market to 2028 | Industry Statistics, Emerging Demands, Forecast to 2028
The global inhibitor of nuclear factor-kappa b kinase subunit beta or IKK? market is expected to grow at a significant CAGR during the forecast period (2022-2028). IKK?, or inhibitor of nuclear factor kappa-B kinase subunit beta, is a protein encoded by the IKBKB (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta) gene in humans. The IKK?, a particular regulator of nuclear factor-B (NF-B), is thought to be a promising target for developing new medications to treat rheumatoid arthritis and cancer.
To Request a Sample of our Report on Inhibitor of
Nuclear Factor Kappa B Kinase Subunit Beta Market: https://www.omrglobal.com/request-sample/Inhibitor-of-nuclear-factor-kappa-b-kinase-subunit-beta-market
IKK? has been proven to be a
therapeutic target for a variety of clinical illnesses, including cancer and
chronic inflammatory diseases. Inflammation is present in a wide range of
disorders and circumstances, including diseases. Allergies, asthma, autoimmune
disorders, celiac disease, glomerulonephritis, hepatitis, inflammatory bowel
disease, preperfusion damage, and transplant rejection are only few of the
conditions that can occur. The rising prevalence of cancer across the globe is
contributing to the growth of the global IKK? market. Breast and lung
cancers were the most frequent cancers globally in 2020, accounting for 12.5%
and 12.2% of all new cases, respectively. With 1.9 million new cases in 2020,
colorectal cancer was the third most frequent cancer, accounting for 10.7% of
all new cases. Lung cancer was the most frequent cancer in men globally in
2020, accounting for 15.4% of all new cases diagnosed. Lung, prostate, and
colorectal cancers accounted for 41.9% of all cancer cases (excluding
non-melanoma skin cancer). Other prevalent tumours that contributed more than
5% were stomach and liver cancers. Breast cancer was the most common cancer
among women globally in 2020, accounting for 25.8% of all new cases diagnosed.
Breast, colorectal, and lung cancers accounted for 44.5% of all cancer cases
(excluding non-melanoma skin cancer). Cervical cancer was the fourth most
frequent cancer among women in 2020, accounting for 6.9% of all new cases
diagnosed.
Market Coverage
·
The market number available for – 2021-2028
·
Base year- 2021
·
Forecast period- 2022-2028
Segment Covered-
·
By Product
·
By Application
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape: Daiichi Sankyo Co Ltd.,
and EntreChem, S.L., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Market
is Available @ https://www.omrglobal.com/industry-reports/Inhibitor-of-nuclear-factor-kappa-b-kinase-subunit-beta-market
Global Inhibitor of Nuclear Factor Kappa B Kinase Subunit
Beta Market Report by Segment
By Product
• TLX-1423
• IMD-0560
• EC-70124
• Others
By Application
• Colorectal
Cancer
• Pancreatic
Cancer
• Prostate
Cancer
• Others
Global Inhibitor of Nuclear Factor Kappa B Kinase Subunit
Beta Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment